References
- Smith, H.J., Simons, C., eds (2002) Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development (Taylor & Francis, London & New York), and references cited therein.
- Woessner, Jr, J.F. and Nagase, H. (2000) Matrix Metalloprotein- ases and TIMPS (Oxford University Press, Oxford), pp 1 – 223.
- Supuran, C.T. and Scozzafava, A. (2002) “Matrix metallo- proteinases (MMPs)”, In: Smith, H.J. and Simons, C., eds, Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development (Taylor & Francis, London & New York), pp 35 – 61.
- Casini, A., Scozzafava, A. and Supuran, C.T. (2002), Exp. Opin. Ther. Patents 12, 1307– 1327.
- Leung, D., Abbenante, G. and Fairlie, D.P. (2000), J. Med. Chem. 43, 305– 341.
- Whittaker, M., Floyd, C.D., Brown, P. and Gearing, A.J.H. (1999) “Design and therapeutic application of matrix metalloproteinase inhibitors”, Chem. Rev. 99, 2735– 2776.
- Supuran, C.T., Scozzafava, A. and Mastrolorenzo, A. (2001), Exp. Opin. Ther. Patents 11, 221– 259.
- Supuran, C.T., Scozzafava, A. and Clare, B.W. (2002), Med. Res. Rev. 22, 329– 372.
- Giavazzi, R. and Taraboletti, G. (2001), Crit. Rev. Oncol. Hematol. 37, 53– 60.
- Hidalgo, M. and Eckhardt, S.G. (2001), J. Natl Cancer 93, 178– 193.
- Gearing, A.J.H., Adams, S.E., Clements, J.C. and Miller, K.M. (1999) “Matrix metalloproteinases in neuroinflammatory disease”, In: Bottomley, K.M.K., Bradshaw, D. and Nixon, J.S., eds, Metalloproteinases as Targets for Anti-Inflammatory Drugs (Birkha¨user Verlag, Basel – Boston – Berlin), pp. 85 – 98.
- Hooper, N.M. (1999) “Overview of the biological roles of metalloproteinases in health and disease”, In: Bottomley, K.M.K., Bradshaw, D. and Nixon, J.S., eds, Metalloproteinases as Targets for Anti-Inflammatory Drugs (Birkha¨user Verlag, Basel – Boston – Berlin), pp 145 – 162.
- Armarego, W.L.F. and Perring, D.D. (1999) Purification of Laboratory Chemicals, 4th edn. (Butterworth-Heinemann Press, Oxford).
- Karlicek, R. and Polasek, M. (1987), Collect. Czech. Chem. Commun. 53, 592.
- Nagase, H. (1997), Biol. Chem. 378, 151– 160.
- Powers, J.C. and Kam, C.M. (1995), Meth. Enzymol. 248, 3– 18.
- Johnson, L.L., Bornemeier, D.A., Janowicz, J.A., Chen, J., Pavlovsky, A.G. and Ortwine, D.F. (1999), J. Biol. Chem. 274, 24881– 24887.
- Bieth, J.G. (1995), Meth. Enzymol. 248, 59– 84.
- Van Wart, H.E. and Steinbrink, D.R. (1981), Anal. Biochem. 113, 156– 165.
- Hanessian, S., Mackay, D.B. and Moitessier, N. (2001), J. Med. Chem. 44, 3074– 3082.
- Smith, R.M. and Martell, A.E. (1989) Critical Stability Constants (Plenum Press, New York) Vol. 6, p 418.